v3.24.3
Condensed Consolidated Statements Of Cash Flows - USD ($)
9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (9,029,973) $ (6,468,769)
Net loss from discontinued operations, net of tax   (1,206,235)
Net loss from continuing operations (9,029,973) (5,262,534)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 2,373,312 4,002,939
Share based compensation (16,199) 966,825
Fair value remeasurement of earnout consideration (800,000) 1,160,000
Fair value remeasurement of warrant liability 974,823  
Fair value remeasurement of embedded derivative liability 468,329  
Fair value remeasurement of contingent value rights (478,809) (1,152,273)
Loss on debt extinguishment 35,657  
Loss (gain) on sale of assets 822 (437,116)
Loss on lease termination 215,415  
Interest and accretion expense 2,312,054 1,867,576
Changes in assets and liabilities:    
Trade accounts receivable 803,047 (112,868)
Inventories 893,281 1,427,729
Income taxes (83,062) (29,081)
Other assets, net (809,709) 2,198,423
Accounts payable 570,844 (510,422)
Accrued compensation and benefits (510,484) 84,421
Customer deposits (270,905) (921,228)
Other accrued liabilities 236,089 (3,095,746)
Accrued interest (1,278,378) (716,188)
Net cash used in operating activities (4,393,846) (529,543)
Net cash used in operating activities - discontinued operations   (295,571)
Net cash used in operating activities (4,393,846) (825,114)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Capital expenditures (29,749) (614,435)
Proceeds from the sale of property, plant and equipment 6,118 450
Proceeds from the sale of investments   2,869,584
Proceeds from earnout consideration on sale of assets   250,000
Net cash (used in) provided by investing activities (23,631) 2,505,599
Net cash provided by investing activities - discontinued operations   1,102,935
Net cash (used in) provided by investing activities (23,631) 3,608,534
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from loans payable 1,604,000 7,814,844
Payments against loans payable (1,161,654) (6,970,811)
Payments related to debt issuance costs (24,150) (348,065)
Payments related to equity issuance costs (237,536)  
Proceeds from the issuance of common stock under registered direct offering 1,000,000  
Proceeds from the issuance of Series B preferred stock 15  
Payments for contingent value rights distributions (3,036,676)
Proceeds from issuance of common stock, net of shares withheld 9,775 125,398
Cash in lieu payment on fractional shares under reverse stock split (1,132)  
Purchase of common stock (6,098) (31,186)
Net cash provided by (used in) financing activities 1,183,220 (2,446,496)
NET (DECREASE) INCREASE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH (3,234,257) 336,924
CASH, CASH EQUIVALENTS AND RESTRICTED CASH AT BEGINNING OF PERIOD 5,396,343 5,256,478
CASH, CASH EQUIVALENTS AND RESTRICTED CASH AT END OF PERIOD 2,162,086 5,593,402
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:    
Income taxes paid 83,100 28,672
Interest paid 1,216,577 688,954
NONCASH FINANCING AND INVESTING ACTIVITIES:    
Gain on extinguishment of related party debt   36,291
Loss on extinguishment of debt (35,657)  
Deemed dividend on Convertible Preferred Stock and PIPE Warrants 11,587,121  
Conversion of redeemable convertible preferred stock to common stock $ 15,277,055  
Operating right of use assets obtained in exchange for lease obligations   $ 753,972

Source